Amphastar Pharmaceuticals, Inc. (AMPH): Cash & Equivalents
$170.18M
As of 2025-12-31
$223.61M
As of 2026-06-30
+2.9%
3-year compound annual growth
+12.9%
5-year compound annual growth
+9.9%
10-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $170.18M | +12.2% | 2026-02-26, Balance as of period end |
| 2024-12-31 | $151.61M | +5.1% | 2026-02-26, Balance as of period end |
| 2023-12-31 | $144.30M | -7.6% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $156.10M | +23.5% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $126.35M | +36.4% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $92.64M | +25.7% | 2022-03-11, Balance as of period end |
| 2019-12-31 | $73.69M | -14.7% | 2021-03-15, Balance as of period end |
| 2018-12-31 | $86.34M | +31.6% | 2020-03-16, Balance as of period end |
| 2017-12-31 | $65.59M | -9.3% | 2019-03-15, Balance as of period end |
| 2016-12-31 | $72.35M | +9.5% | 2018-03-14, Balance as of period end |
| 2015-12-31 | $66.07M | -2.6% | 2018-03-14, Balance as of period end |
| 2014-12-31 | $67.83M | +26.6% | 2017-03-15, Balance as of period end |
| 2013-12-31 | $53.59M | +6.7% | 2016-03-15, Balance as of period end |
| 2012-12-31 | $50.21M | n/a | 2015-03-26, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Amphastar Pharmaceuticals, Inc. (AMPH) | 2025-12-31 | $170.18M | +12.2% |
| Supernus Pharmaceuticals, Inc. (SUPN) | 2025-12-31 | $128.45M | +85.3% |
| Pacira BioSciences, Inc. (PCRX) | 2025-12-31 | $158.54M | -42.7% |
| Emergent BioSolutions Inc. (EBS) | 2025-12-31 | $205.40M | +106.4% |
| Corcept Therapeutics Inc (CORT) | 2025-12-31 | $120.50M | -5.6% |
| Kiniksa Pharmaceuticals International, plc (KNSA) | 2025-12-31 | $165.60M | -9.8% |
| Ultragenyx Pharmaceutical Inc. (RARE) | 2025-12-31 | $421.00M | +142.0% |
| Collegium Pharmaceutical, Inc (COLL) | 2025-12-31 | $231.25M | +227.7% |
| Axsome Therapeutics, Inc. (AXSM) | 2025-12-31 | $322.93M | +2.4% |
Compare AMPH, SUPN, PCRX, EBS side by side · Screen every company in Pharmaceutical Preparations ↗